Nothing attracts readers like including Hollywood in the headlines, HBW Insight’s top story for 2020 suggests.
Otherwise, HBW Insight’s coverage of the US OTC drug and dietary supplement industries garnered most readers with articles on federal legislation responding to the COVID-19 pandemic that granted the Food and Drug Administration authority to overhaul its OTC drug monograph program
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?